Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 9,060 $ 9,397
Accounts receivable, net 5,240 25,304
Non-trade receivable 4,322 961
Related party receivable 644
Inventory 12,374 6,517
Prepaid expenses and other current assets 2,224 1,608
Total current assets 33,864 43,787
Property and equipment, net 239 71
Contract fulfillment assets 12,063 9,232
Other assets 2,981 2,953
Total assets 49,147 56,043
Liabilities and stockholders’ equity    
Accounts payable 9,056 19,847
Accrued liabilities 23,128 12,300
Total current liabilities 32,184 32,147
Income tax payable 1,614 1,528
Total liabilities 33,798 33,675
Commitments and contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.001 par value per share; 100,000,000 shares authorized: and 4,871,639 and 4,426,867 shares issued and outstanding at September 30, 2024, and December 31, 2023, respectively [1] 5 4
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at September 30, 2024, and December 31, 2023, respectively
Additional paid-in capital [1] 277,338 272,324
Accumulated deficit (261,994) (249,960)
Total stockholders’ equity 15,349 22,368
Total liabilities and stockholders’ equity $ 49,147 $ 56,043
[1] Adjusted retroactively to reflect the 1-for-10 reverse stock split that became effective on July 17, 2024, see Note 1.